Next in Health
A weekly healthcare podcast series hosted by PwC's Health Research Institute that addresses industry trends and timely health policy topics impacting patients, providers, payers, pharmaceutical and life sciences companies as well as vendors and new entrants.
Episodes
48 episodes
PwC's 2025 Medical cost trend report reveals rising healthcare costs
Tune in as authors of PwC's 2025 Medical Cost Trend Report: Behind the Numbers, discuss key findings and provide what employers should consider to manage rising healthcare costs. Key points include:Cost projections: The...
•
Season 5
•
Episode 4
•
21:54
The importance of physician enablement to our health ecosystem
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Director, Rohit Nayak, PwC Strategy& Senior Manager, Sri Murthy Guru and PwC Strategy& Senior Assoc...
•
Season 3
•
Episode 23
•
18:03
How emerging companies are navigating growth in the health industry
Tune in as PwC specialists discuss how emerging companies (private, pre-IPO) are navigating growth in the health industry. Key topics include:The journey and milestones of emerging companies in the life sciences, biotec...
•
Season 5
•
Episode 3
•
21:13
2024 Outlook: Healthcare's big squeeze and the way out
Tune in as PwC specialists discuss the 2024 outlook for healthcare and how the sector can grow and innovate amid economic challenges and uncertainty. Key Topics include:Major forces impacting the sector: economic pressu...
•
Season 5
•
Episode 2
•
17:55
Reinventing for returns: what's next in pharma?
Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry. Key topics include:The headwinds for pharma are real and sustained ...
•
Season 5
•
Episode 1
•
13:56
The year in Deals: Preparing for 2024
Tune in to hear PwC Deals leaders discuss preparing for deals in 2024, exploring the current state of the deals market and sharing valuable insights from their newly released 2024 deals outlook. Key topics include:Fundamental change...
•
Season 4
•
Episode 41
•
26:56
Transforming healthcare collaboration through the power of health ecospheres
Tune in to hear PwC specialists discuss how health ecospheres can provide a transformative model for organizations to collaborate and address large-scale healthcare problems. Topics include:Identifying areas of historical shortcomin...
•
Season 4
•
Episode 40
•
15:36
Harnessing data insights: Revolutionizing healthcare and costs for patients with complex chronic conditions
Tune in as health leader, author and entrepreneur, Stephen Pollak, PhD, shares how the outcomes of his research in hemodialysis populations and beyond are paving the path for data-driven solutions that inform and integrate care for patients wit...
•
Season 4
•
Episode 39
•
33:17
The secret to attracting and retaining healthcare consumers
Tune in to hear PwC specialists discuss re-engineering the healthcare ecosystem by engaging healthcare consumers. Topics include: Evaluating the consumer experience and engagementTrends in the market to help organizati...
•
Season 4
•
Episode 38
•
19:27
Transforming Ukraine’s healthcare infrastructure for a sustainable future
Tune in to hear Barrett Baker of Project Horizon from the Sunflower Network, and Dan Solchanyk from Razom, discuss how to strengthen Ukraine’s healthcare infrastructure both for the near and the long term. Topics include:Sunflower N...
•
Season 4
•
Episode 37
•
22:53
Future-proofing behavioral health care: Innovations to ensure no one is left behind
Tune in to hear Chris Barnett, Chris Barnett, CEO of ABA Centers of America, discuss his approach to a comprehensive healthcare system, with a specific emphasis on new models, technologies, and algorithms that promote inclusivity for improved b...
•
Season 4
•
Episode 35
•
14:38
Key strategies for global pharma companies to reduce risk and drive growth in the China market
Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include:Sharing key strategies for p...
•
Season 4
•
Episode 36
•
15:52
How technology is helping to transform behavioral and mental health care across the globe
People across the world are suffering from behavioral and mental health challenges. Tune in to hear Eric Hren, Chief Growth Officer at Innowell, discuss how technology can help provide better services and solutions for patients, clinicians and ...
•
Season 4
•
Episode 34
•
22:45
The potential of GenAI in health care
Tune in to hear PwC specialists discuss the functionality and benefits of using GenAI in health care. Topics include:How GenAI is being used todayGenAI helping health insurers drive affordability of healthcareHealt...
•
Season 4
•
Episode 33
•
16:19
What to know about using GenAI in the pharma and life sciences industry
Tune in to hear PwC specialists discuss using GenAI in the pharma and life sciences industry. Topics include:Key considerations for new technology and deploying GenAI responsiblyKey elements to consider for monitoring regul...
•
Season 4
•
Episode 32
•
33:43
The SCAN Group reinvents coverage and care for the seniors
Tune in to hear how the SCAN Group is expanding their Medicare Advantage plan by launching new care entities that aim to address problems of older adults. Topics include:•Addressing national-scale industry issues such as affordability an...
•
Season 4
•
Episode 31
•
29:29
Transforming consumer and patient engagement in life sciences
Tune in to hear PwC specialists discuss how life sciences companies are engaging better with consumers and patients and rethinking engagement, the channels utilized and how to utilize data and technology to create meaningful impact. Topics incl...
•
Season 4
•
Episode 30
•
15:52
Key findings from PwC's medical trend cost report, Behind the Numbers 2024
Tune in to hear PwC specialists share key findings from their medical cost trend report, discussing healthcare affordability and its implications for employers and consumers. Topics include: The Macroeconomics environment: The ...
•
Season 4
•
Episode 29
•
17:26
The year in Deals 2023 and beyond
Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the deals landscape 2023 and offer a preview of what lies ahead. Topics include:A look back at M&A activity in health industries so far ...
•
Season 4
•
Episode 28
•
21:51
Innovations in oncology
Tune in to hear how innovations in science, technology, reimbursement, and organizational collaboration are reshaping the oncology landscape. Topics include:Emerging therapies and new business models to drive cost efficiencies ...
•
Season 4
•
Episode 27
•
13:07
Better Care for the Elderly
Tune in to hear Robbie Pottharst, CEO of myPlace Health, discuss their mission for building a health care startup to integrate better care for the elderly. Topics include:What is the PACE model?How myPlace Health wo...
•
Season 4
•
Episode 26
•
11:11
How the finance function is helping to build the future of healthcare
Tune in to hear how the functional role of finance can influence companies’ strategies for growth in the pharmaceutical and life sciences industry. Topics include:Challenging the operating model to get Fit for Growth: Four steps to ...
•
Season 4
•
Episode 24
•
27:31
Revolutionizing healthcare experiences through immersive technology
Tune in to hear how incorporating immersive technology in healthcare opens new frontiers; enabling patients to embark on transformative virtual health journeys to enhance their outcomes and user experience. Topics include:Examples o...
•
Season 4
•
Episode 25
•
14:13
What pharma stakeholders need to know about the Drug Supply Chain Security Act (DSCSA)
Tune in to hear what pharma stakeholders should know about the implementation of the Drug Supply Chain Security Act. Topics include:The objective of the Drug Supply Chain Security Act and timelineSteps pharma stakeholders n...
•
Season 4
•
Episode 23
•
19:16
Enabling chat platforms to connect the the prescribing physicians to the manufacturers of the medications
Tune in to hear how pharmaceutical and life sciences companies are shifting their interactions with healthcare providers to be more helpful and informative, consolidate outreach and streamline compliance using chat platforms. Topics include:
•
Season 4
•
Episode 22
•
14:13